Charles M. Baum

Insider Reports History

Location: C/O Mirati Therapeutics Inc., 9393 Towne Centre Drive, Ste 200, San Diego, CA
Signature: /s/ Johanna Mylet, Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles M. Baum:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Poseida Therapeutics, Inc.	Director	Common Stock	0	$0	$9.60	Jan 8, 2025	Direct
PMV Pharmaceuticals, Inc.	Director	Stock Option (right to buy)	67.5K			Jun 6, 2024	Direct
Acrivon Therapeutics, Inc.	Director	Stock Option (Right to Buy)	20.3K			Jun 20, 2024	Direct
Mirati Therapeutics, Inc.	Founder, President, and CEO, Director	Common Stock	0		$59.02	Jan 23, 2024	Direct
Mirati Therapeutics, Inc.	Founder, President, and CEO, Director	Option to Purchase Common Stock	0			Jan 23, 2024	Direct
Poseida Therapeutics, Inc.	Director	Stock Option (Right to Buy)	0			Jan 8, 2025	Direct

Previous1Next

Showing 1 to 6 of 6 entries

Insider Reports Filed by Charles M. Baum

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
PSTX	Poseida Therapeutics, Inc.	Jan 8, 2025	4	$0	4	Jan 8, 2025	Director
ACRV	Acrivon Therapeutics, Inc.	Jun 20, 2024	1	$0	4	Jun 24, 2024	Director
PSTX	Poseida Therapeutics, Inc.	Jun 17, 2024	2	$0	4	Jun 18, 2024	Director
PMVP	PMV Pharmaceuticals, Inc.	Jun 6, 2024	1	$0	4	Jun 10, 2024	Director
MRTX	Mirati Therapeutics, Inc.	Jan 23, 2024	11	$0	4	Jan 23, 2024	Founder, President, and CEO, Director
MRTX	Mirati Therapeutics, Inc.	Dec 29, 2023	1	$1.2M	4	Jan 3, 2024	Interim CEO, Director
MRTX	Mirati Therapeutics, Inc.	Aug 9, 2023	1	$2M	4	Aug 10, 2023	Interim CEO, Director
ACRV	Acrivon Therapeutics, Inc.	Jun 22, 2023	1	$0	4	Jun 28, 2023	Director
ACRV	Acrivon Therapeutics, Inc.	Jun 22, 2023	0	$0	3	Jun 28, 2023	Director
PSTX	Poseida Therapeutics, Inc.	Jun 15, 2023	2	$0	4	Jun 16, 2023	Director
PMVP	PMV Pharmaceuticals, Inc.	Jun 8, 2023	1	$0	4	Jun 12, 2023	Director
MRTX	Mirati Therapeutics, Inc.	Jan 20, 2023	2	$0	4	Jan 24, 2023	President,Founder,Head of R&D, Director
MRTX	Mirati Therapeutics, Inc.	Jan 4, 2023	1	-$170K	4	Jan 5, 2023	President,Founder,Head of R&D, Director
MRTX	Mirati Therapeutics, Inc.	Dec 19, 2022	2	-$367K	4	Dec 21, 2022	President,Founder,Head of R&D, Director
MRTX	Mirati Therapeutics, Inc.	Nov 28, 2022	3	-$5.72M	4	Nov 28, 2022	President,Founder,Head of R&D, Director
PSTX	Poseida Therapeutics, Inc.	Jun 16, 2022	2	$0	4	Jun 16, 2022	Director
PMVP	PMV Pharmaceuticals, Inc.	Jun 2, 2022	1	$0	4	Jun 6, 2022	Director
PSTX	Poseida Therapeutics, Inc.	May 16, 2022	0	$0	3	May 18, 2022	Director
MRTX	Mirati Therapeutics, Inc.	Jan 14, 2022	5	-$203K	4	Jan 18, 2022	President,Founder,Head of R&D, Director
MRTX	Mirati Therapeutics, Inc.	Jan 4, 2022	2	-$608K	4	Jan 6, 2022	President,Founder,Head of R&D, Director
MRTX	Mirati Therapeutics, Inc.	Dec 16, 2021	1	$0	4	Dec 17, 2021	President & CEO, Director
MRTX	Mirati Therapeutics, Inc.	Dec 3, 2021	9	-$5.89M	4	Dec 3, 2021	President & Head of R&D, Director
MRTX	Mirati Therapeutics, Inc.	Jun 18, 2021	6	-$6.28M	4	Jun 21, 2021	President & CEO, Director
PMVP	PMV Pharmaceuticals, Inc.	Jun 2, 2021	1	$0	4	Jun 9, 2021	Director